Bausch Health Cos., Inc. (BHC)
6.32
+0.02
(+0.32%)
USD |
NYSE |
Aug 28, 14:57
Bausch Health Cos. Market Cap : 2.363B for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 27, 2026 | 2.356B |
| August 26, 2026 | 2.434B |
| August 25, 2026 | 2.516B |
| August 24, 2026 | 2.498B |
| August 21, 2026 | 2.408B |
| August 20, 2026 | 2.546B |
| August 19, 2026 | 2.576B |
| August 18, 2026 | 2.591B |
| August 17, 2026 | 2.460B |
| August 14, 2026 | 2.434B |
| August 13, 2026 | 2.371B |
| August 12, 2026 | 2.322B |
| August 11, 2026 | 2.333B |
| August 10, 2026 | 2.374B |
| August 07, 2026 | 2.337B |
| August 06, 2026 | 2.210B |
| August 05, 2026 | 2.352B |
| August 04, 2026 | 2.408B |
| August 03, 2026 | 2.617B |
| July 31, 2026 | 2.576B |
| July 30, 2026 | 2.255B |
| July 29, 2026 | 1.750B |
| July 28, 2026 | 1.690B |
| July 27, 2026 | 1.673B |
| July 24, 2026 | 1.654B |
| Date | Value |
|---|---|
| July 23, 2026 | 1.662B |
| July 22, 2026 | 1.703B |
| July 21, 2026 | 1.688B |
| July 20, 2026 | 1.748B |
| July 17, 2026 | 1.804B |
| July 16, 2026 | 1.841B |
| July 15, 2026 | 1.826B |
| July 14, 2026 | 1.774B |
| July 13, 2026 | 1.811B |
| July 10, 2026 | 1.785B |
| July 09, 2026 | 1.815B |
| July 08, 2026 | 1.834B |
| July 07, 2026 | 1.834B |
| July 06, 2026 | 1.796B |
| July 02, 2026 | 1.830B |
| July 01, 2026 | 1.781B |
| June 30, 2026 | 1.841B |
| June 29, 2026 | 1.811B |
| June 26, 2026 | 1.778B |
| June 25, 2026 | 1.972B |
| June 24, 2026 | 1.864B |
| June 23, 2026 | 1.793B |
| June 22, 2026 | 1.744B |
| June 18, 2026 | 1.781B |
| June 17, 2026 | 1.778B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 4.673M |
| NervGen Pharma Corp. | 239.43M |
| Milestone Pharmaceuticals, Inc. | 143.17M |
| Clearmind Medicine, Inc. | 1.794M |
| Lexaria Bioscience Corp. | 17.68M |
Market Cap Related Metrics
| PS Ratio | 0.2179 |
| Price to Free Cash Flow | 1.717 |
| Price | 6.32 |
| Earnings Yield | -46.84% |
| Operating PE Ratio | 0.8657 |
| Normalized PE Ratio | 11.61 |